T2 Biosystems Inc EV/EBITDA
Что обозначает EV/EBITDA в T2 Biosystems Inc?
EV/EBITDA T2 Biosystems Inc является N/A
Какое определение для EV/EBITDA?
EV / EBITDA - это стоимость предприятия, деленная на прибыль до вычета процентов, налогов, обесценивания и амортизации. При помощи неё измеряется, насколько дорогой является акция, и она более действительна для сравнения компаний, чем для соотношения цены и прибыли. Она измеряет цену (в форме стоимости предприятия), которую инвестор платит в пользу денежного потока компании (в форме EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с T2 Biosystems Inc
Что делает T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Компании с ev/ebitda похож на T2 Biosystems Inc
- Prime Intelligence Solutions имеет EV/EBITDA из N/A
- K.B. Recycling Industries имеет EV/EBITDA из N/A
- Forward Water Technologies имеет EV/EBITDA из N/A
- Fjordland Exploration имеет EV/EBITDA из N/A
- Aquarius AI имеет EV/EBITDA из N/A
- Sipa Resources имеет EV/EBITDA из N/A
- T2 Biosystems Inc имеет EV/EBITDA из N/A
- RightCrowd имеет EV/EBITDA из N/A
- China Strategic имеет EV/EBITDA из N/A
- Deliveroo Plc имеет EV/EBITDA из N/A
- Singulus Technologies AG имеет EV/EBITDA из N/A
- Inventiva S.A имеет EV/EBITDA из N/A
- Pascal Biosciences имеет EV/EBITDA из N/A